Cargando…

Coronavirus disease 2019 vaccines: challenges of using global mass vaccination to achieve herd immunity

Detalles Bibliográficos
Autores principales: Bao, Pengtao, Gong, Jiuyu, Mu, Mi, Que, Yifan, Hu, Peng, Luo, Jiang, Chang, Christopher, Xu, Guogang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10325752/
https://www.ncbi.nlm.nih.gov/pubmed/36806245
http://dx.doi.org/10.1097/CM9.0000000000002270
_version_ 1785069288165474304
author Bao, Pengtao
Gong, Jiuyu
Mu, Mi
Que, Yifan
Hu, Peng
Luo, Jiang
Chang, Christopher
Xu, Guogang
author_facet Bao, Pengtao
Gong, Jiuyu
Mu, Mi
Que, Yifan
Hu, Peng
Luo, Jiang
Chang, Christopher
Xu, Guogang
author_sort Bao, Pengtao
collection PubMed
description
format Online
Article
Text
id pubmed-10325752
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-103257522023-07-07 Coronavirus disease 2019 vaccines: challenges of using global mass vaccination to achieve herd immunity Bao, Pengtao Gong, Jiuyu Mu, Mi Que, Yifan Hu, Peng Luo, Jiang Chang, Christopher Xu, Guogang Chin Med J (Engl) Correspondence Lippincott Williams & Wilkins 2023-07-05 2023-02-13 /pmc/articles/PMC10325752/ /pubmed/36806245 http://dx.doi.org/10.1097/CM9.0000000000002270 Text en Copyright © 2023 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
spellingShingle Correspondence
Bao, Pengtao
Gong, Jiuyu
Mu, Mi
Que, Yifan
Hu, Peng
Luo, Jiang
Chang, Christopher
Xu, Guogang
Coronavirus disease 2019 vaccines: challenges of using global mass vaccination to achieve herd immunity
title Coronavirus disease 2019 vaccines: challenges of using global mass vaccination to achieve herd immunity
title_full Coronavirus disease 2019 vaccines: challenges of using global mass vaccination to achieve herd immunity
title_fullStr Coronavirus disease 2019 vaccines: challenges of using global mass vaccination to achieve herd immunity
title_full_unstemmed Coronavirus disease 2019 vaccines: challenges of using global mass vaccination to achieve herd immunity
title_short Coronavirus disease 2019 vaccines: challenges of using global mass vaccination to achieve herd immunity
title_sort coronavirus disease 2019 vaccines: challenges of using global mass vaccination to achieve herd immunity
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10325752/
https://www.ncbi.nlm.nih.gov/pubmed/36806245
http://dx.doi.org/10.1097/CM9.0000000000002270
work_keys_str_mv AT baopengtao coronavirusdisease2019vaccineschallengesofusingglobalmassvaccinationtoachieveherdimmunity
AT gongjiuyu coronavirusdisease2019vaccineschallengesofusingglobalmassvaccinationtoachieveherdimmunity
AT mumi coronavirusdisease2019vaccineschallengesofusingglobalmassvaccinationtoachieveherdimmunity
AT queyifan coronavirusdisease2019vaccineschallengesofusingglobalmassvaccinationtoachieveherdimmunity
AT hupeng coronavirusdisease2019vaccineschallengesofusingglobalmassvaccinationtoachieveherdimmunity
AT luojiang coronavirusdisease2019vaccineschallengesofusingglobalmassvaccinationtoachieveherdimmunity
AT changchristopher coronavirusdisease2019vaccineschallengesofusingglobalmassvaccinationtoachieveherdimmunity
AT xuguogang coronavirusdisease2019vaccineschallengesofusingglobalmassvaccinationtoachieveherdimmunity